Skip to main content

Carlos Nos Llopis

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Carlos Nos Llopis

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

UNiC-Unitat de Neuroimmunologia Clínica

IP: Xavier Montalban Gairín
Collaborators: Carlos Nos Llopis, Jordi Rio Izquierdo, Manuel Comabella Lopez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Mireia Castillo Juarez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35600
Reference: 2005SGR 01081
Duration: 01/01/2006 - 31/12/2008

Estudio predictivo de la falta de respuesta al interferon beta en pacientes con esclerosis múltiple.

IP: Jordi Rio Izquierdo
Collaborators: Carlos Nos Llopis, M Jesus Arevalo Navines
Funding agency: Instituto de Salud Carlos III
Funding: 36800
Reference: PI030173
Duration: 01/01/2003 - 28/11/2006

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Cristina Salon Ajenjo

Cristina Salon Ajenjo

Read more
Maria Margaret Mercadal Hally

Maria Margaret Mercadal Hally

Research technician
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Marina Hortola Bufi

Marina Hortola Bufi

Read more
Adrian Nuñez Cardoso

Adrian Nuñez Cardoso

Research technician
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.